German Cancer Research Center-DKFZ (Heidelberg, Germany)




The German Cancer Research Center (DKFZ) is one of the world’s leading biomedical research institutions. It serves the mission to identify and study cancer risk factors and to unravel mechanisms of cancer development.
The findings from our basic research are systematically employed to develop new approaches for prevention, diagnosis and treatment.

The 54 scientific divisions, 25 junior research groups and 12 clinical cooperation units are assigned to seven Research Programs:

  • Cell Biology and Tumor Biology
  • Functional and Structural Genomics
  • Cancer Risk Factors and Prevention
  • Tumor Immunology
  • Imaging and Radiooncology
  • Inflammation, Infection and Cancer
  • Translational Cancer Research

Jointly with the Heidelberg University Hospital, DKFZ has established the National Center for Tumor Diseases Heidelberg where promising approaches from cancer research are translated into the clinic.

In 2011, the German Cancer Consortium was introduced to the public by the BMBF, the German Federal Ministry of Education and Research, as one of six German Centers for Health Research. This initiative intends to foster the nationwide strategic collaboration of the most excellent scientists and clinicians in exploring common cancer diseases.

The National Centre for Tumor Diseases in Heidelberg (NCT) is the leading National Cancer Center in Germany.  The NCT was founded in 2004 by the German Cancer Research Center (DKFZ), the Heidelberg University Hospital , the Medical Faculty Heidelberg and German Cancer Aid (Deutsche Krebshilfe). They secure the financing and support the NCT through infrastructure and resources.